Sofinnova Partners Archives

digital medicine artificial intelligence AI

News and Trends 31 Mar 2023

Sofinnova Partners dives into digital medicine, funds new companies

Sofinnova Partners, a European life sciences venture capital firm based in Paris, London, and Milan, has launched a new investment strategy focused on digital medicine. The strategy, which has already…

March 31, 2023 - 5 minutesmins - By Jim Cornall

Interview 21 Jul 2022

Finding investment opportunities in a bleak biotech stock market

The situation remains difficult in public markets as biotech stocks struggle to recover from a 50% decline over the past year. However, the venture capital (VC) firm Sofinnova Partners is…

July 21, 2022 - 7 minutesmins - By Jonathan Smith

News and Trends 17 May 2022

US Giant Apollo Bags Billion-Euro Partnership with Sofinnova

As biotech investment slows following a record-breaking year, the Paris-based Sofinnova Partners has landed a €1B collaboration deal with the US investment heavyweight Apollo to nurture life sciences companies. Cementing…

May 17, 2022 - 3 minutesmins - By Anita Chakraverty

Antoine Papiernik Sofinnova Partners life science

Opinion 14 Mar 2022

The Secrets to 50 Years of Success in Life Sciences Investment

The European life sciences venture capital firm Sofinnova Partners is celebrating its 50th birthday this year. Sofinnova’s Chairman and Managing Partner, Antoine Papiernik, outlines key lessons the company has learned…

March 14, 2022 - 7 minutesmins - By Antoine Papiernik

News and Trends 10 Dec 2021

European Biotech Investors Cap Off Record Year in Fundraising

The year 2021 is closing with a biotech investment rush as Eir Ventures, Apollo Health Ventures, and Merck’s venture capital arm M Ventures raise impressive funds to speed up life…

December 10, 2021 - 4 minutesmins - By Jonathan Smith

Industrial biotech sustainability environment

News and Trends 18 Nov 2021

Sustainability in Focus as Two VCs Build Industrial Biotech Funds

As this month’s COP26 United Nations climate summit highlighted the climate change emergency, venture capital fundraises from Sofinnova and the European Circular Bioeconomy Fund have led the push for industrial…

November 18, 2021 - 4 minutesmins - By Anita Chakraverty

News and Trends 19 Oct 2021

Biotech VCs Face Funding Bulge Amid Struggling Stock Markets

Despite volatile biotech stocks limiting options for exit, Sofinnova Partners’ latest €472M fund highlights ballooning European venture capital and its growing focus on early-stage biotech investments. Biotech fundraising broke records…

October 19, 2021 - 5 minutesmins - By Jonathan Smith

uk vc firm investment biotech life sciences

News and Trends 16 Jul 2021

Multi-Million UK Life Sciences Initiative Welcomed By VC Firms

Biotech venture capital firms across Europe have warmly received the launch of a €235M (£200M) UK government initiative to support the growth of promising late-stage life sciences companies. The UK’s…

July 16, 2021 - 4 minutesmins - By Anita Chakraverty

News and Trends 12 Jul 2021

Sofinnova Taps into Italian Gene Therapy with Three Seed Financings

The French investor Sofinnova Partners has injected a total of €6M into three Italian gene therapy companies, cementing Italy’s reputation as a European center for cell and gene therapies. Last…

July 12, 2021 - 5 minutesmins - By Anita Chakraverty

Antoine Papiernik Sofinnova Partners Biotech Entrepreneurs

Opinion 8 Mar 2021

Advice for my Younger Self: How to Be a VC in Life Sciences

Antoine Papiernik, Chairman and Managing Partner at Sofinnova Partners, looks back at where he was two decades ago and shares what he would tell his younger self about being a…

March 8, 2021 - 5 minutesmins - By Antoine Papiernik

News and Trends 4 Dec 2020

EU Launches Pharma Strategy, Raising Both Hopes and Questions

The public's response has been cautious after the European Union unveiled a pharmaceutical strategy last week designed to spur domestic innovation and the production of affordable, state-of-the-art therapies. Amid a…

December 4, 2020 - 6 minutesmins - By Victor Kotsev

News and Trends 1 Oct 2020

Medicxi to Shake up the Biotech VC Investment Model with €200M Fund

UK-based investment firm Medicxi aims to attract more investors to the life sciences with a new fund that lets them cash in on their investments earlier than conventional funds. Last…

October 1, 2020 - 4 minutesmins - By Victor Kotsev

News and Trends 13 Aug 2020

Why are Some European Biotechs Going Public Without an IPO?

European biotech companies are flocking to the Nasdaq Stock Market in 2020, but not all are going the traditional Initial Public Offering (IPO) route. What does this mean for the…

August 13, 2020 - 7 minutesmins - By Jonathan Smith

News and Trends 15 Jun 2020

Chilean Biotech Moves to France to Develop Anti-Mold Food Preservative

The startup Protera is moving from Santiago de Chile to Paris following a €5M Series A round that will let the company scale up the production of an antifungal protein…

June 15, 2020 - 4 minutesmins - By David Kirk

News and Trends 27 Apr 2020

Series A Round Boosts Swedish Synthetic Biology Player by €6.4M

The Swedish synthetic biology company EnginZyme has raised a Series A funding round to the tune of €6.4M to develop its cell-free synbio technology for the sustainable production of plastic,…

April 27, 2020 - 4 minutesmins - By Karen O’Hanlon Cohrt

Orchard therapeutics gene therapy header

News and Trends 23 Apr 2020

Sofinnova Invests €20M in Three Italian Rare Disease Biotechs

The French VC firm Sofinnova Partners has invested €20M in three Italian biotech companies via its Telethon Fund, which focuses on firms developing treatments for rare diseases. The deals by…

April 23, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 16 Jan 2020

Biotech Investment Firm Jeito Capital Launches with €200M Fund

The French investment firm Jeito Capital has launched this week with a €200M fund that will support up to 15 drug-development start-ups with a focus on European companies. Jeito Capital…

January 16, 2020 - 2 minutesmins - By External Contributor

Expert Advice 15 Jan 2020

How to Spot a Biotech Winner: Investment Lessons from Sofinnova

Making one biotech a success is hard enough, but correctly predicting multiple winners is the bread and butter of Antoine Papiernik, Managing Partner of Sofinnova Partners, one of the biggest…

January 15, 2020 - 10 minutesmins - By Helen Albert

In Depth 14 Jan 2020

What’s the Secret to Making Returns in Industrial Biotech?

As industrial biotech starts gaining more and more traction, investors need to change their mindset in order to start making returns in this promising field. Microorganisms have been helping us…

January 14, 2020 - 3 minutesmins - By Clara Rodríguez Fernández

More News! 20 Nov 2019

€39M Series B to Fund Biopolymers for Surgery and Implants

The French company Tissium has raised a €38.8M Series B round to fund the development of polymers that can be used to repair blood vessels and nerves. Contributing to…

November 20, 2019 - 2 minutesmins - By Jonathan Smith

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

The Biotech Perspective 2023

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering